nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—Peripheral vascular disorder—Varenicline—nicotine dependence	0.0156	0.0263	CcSEcCtD
Eletriptan—CYP2A6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0142	0.0451	CbGpPWpGaD
Eletriptan—Vaginal discharge—Varenicline—nicotine dependence	0.0126	0.0212	CcSEcCtD
Eletriptan—Psoriasis—Varenicline—nicotine dependence	0.0122	0.0205	CcSEcCtD
Eletriptan—Parosmia—Varenicline—nicotine dependence	0.0118	0.0199	CcSEcCtD
Eletriptan—Menstrual disorder—Varenicline—nicotine dependence	0.0113	0.0189	CcSEcCtD
Eletriptan—Haematemesis—Varenicline—nicotine dependence	0.011	0.0186	CcSEcCtD
Eletriptan—Mania—Varenicline—nicotine dependence	0.0106	0.0177	CcSEcCtD
Eletriptan—Menorrhagia—Varenicline—nicotine dependence	0.0104	0.0174	CcSEcCtD
Eletriptan—Gingivitis—Varenicline—nicotine dependence	0.00978	0.0164	CcSEcCtD
Eletriptan—CYP2A6—Xenobiotics—CYP2A7—nicotine dependence	0.00881	0.028	CbGpPWpGaD
Eletriptan—Accidental injury—Varenicline—nicotine dependence	0.00867	0.0146	CcSEcCtD
Eletriptan—Chest discomfort—Varenicline—nicotine dependence	0.00867	0.0146	CcSEcCtD
Eletriptan—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00866	0.0275	CbGpPWpGaD
Eletriptan—Viral infection—Varenicline—nicotine dependence	0.0085	0.0143	CcSEcCtD
Eletriptan—Thinking abnormal—Varenicline—nicotine dependence	0.00838	0.0141	CcSEcCtD
Eletriptan—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00797	0.0253	CbGpPWpGaD
Eletriptan—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0079	0.0251	CbGpPWpGaD
Eletriptan—Coordination abnormal—Varenicline—nicotine dependence	0.00782	0.0131	CcSEcCtD
Eletriptan—Blood pressure increased—Varenicline—nicotine dependence	0.00768	0.0129	CcSEcCtD
Eletriptan—Abnormal dreams—Varenicline—nicotine dependence	0.00759	0.0127	CcSEcCtD
Eletriptan—Eructation—Varenicline—nicotine dependence	0.00754	0.0127	CcSEcCtD
Eletriptan—Salivary hypersecretion—Varenicline—nicotine dependence	0.00745	0.0125	CcSEcCtD
Eletriptan—Photophobia—Varenicline—nicotine dependence	0.00721	0.0121	CcSEcCtD
Eletriptan—Dry eye—Varenicline—nicotine dependence	0.00709	0.0119	CcSEcCtD
Eletriptan—Oesophagitis—Varenicline—nicotine dependence	0.00701	0.0118	CcSEcCtD
Eletriptan—Urine output increased—Varenicline—nicotine dependence	0.00694	0.0117	CcSEcCtD
Eletriptan—Hypertonia—Varenicline—nicotine dependence	0.00673	0.0113	CcSEcCtD
Eletriptan—Mental disability—Varenicline—nicotine dependence	0.00666	0.0112	CcSEcCtD
Eletriptan—Euphoric mood—Varenicline—nicotine dependence	0.00659	0.0111	CcSEcCtD
Eletriptan—Lymphadenopathy—Varenicline—nicotine dependence	0.00653	0.011	CcSEcCtD
Eletriptan—Sleep disorder—Varenicline—nicotine dependence	0.00644	0.0108	CcSEcCtD
Eletriptan—HTR1F—Monoamine GPCRs—DRD2—nicotine dependence	0.00641	0.0203	CbGpPWpGaD
Eletriptan—HTR1F—brain—nicotine dependence	0.00641	0.0825	CbGeAlD
Eletriptan—Polyuria—Varenicline—nicotine dependence	0.00635	0.0107	CcSEcCtD
Eletriptan—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00622	0.0197	CbGpPWpGaD
Eletriptan—Sumatriptan—DRD2—nicotine dependence	0.00621	0.514	CrCbGaD
Eletriptan—Eczema—Varenicline—nicotine dependence	0.0062	0.0104	CcSEcCtD
Eletriptan—Eye pain—Varenicline—nicotine dependence	0.00617	0.0104	CcSEcCtD
Eletriptan—Injury—Varenicline—nicotine dependence	0.00606	0.0102	CcSEcCtD
Eletriptan—HTR1E—Monoamine GPCRs—DRD2—nicotine dependence	0.00604	0.0192	CbGpPWpGaD
Eletriptan—Increased appetite—Varenicline—nicotine dependence	0.00593	0.00996	CcSEcCtD
Eletriptan—Amnesia—Varenicline—nicotine dependence	0.00593	0.00996	CcSEcCtD
Eletriptan—Atrial fibrillation—Varenicline—nicotine dependence	0.00588	0.00988	CcSEcCtD
Eletriptan—Thirst—Varenicline—nicotine dependence	0.00585	0.00984	CcSEcCtD
Eletriptan—Arthritis—Varenicline—nicotine dependence	0.00573	0.00963	CcSEcCtD
Eletriptan—Osteoarthritis—Varenicline—nicotine dependence	0.00557	0.00936	CcSEcCtD
Eletriptan—HTR1E—brain—nicotine dependence	0.00555	0.0715	CbGeAlD
Eletriptan—Migraine—Varenicline—nicotine dependence	0.00548	0.00921	CcSEcCtD
Eletriptan—Affect lability—Varenicline—nicotine dependence	0.00548	0.00921	CcSEcCtD
Eletriptan—HTR1F—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00539	0.0171	CbGpPWpGaD
Eletriptan—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00537	0.017	CbGpPWpGaD
Eletriptan—HTR1B—cardiovascular system—nicotine dependence	0.00535	0.0689	CbGeAlD
Eletriptan—Mood swings—Varenicline—nicotine dependence	0.00528	0.00887	CcSEcCtD
Eletriptan—HTR1D—cardiovascular system—nicotine dependence	0.00518	0.0667	CbGeAlD
Eletriptan—Liver function test abnormal—Varenicline—nicotine dependence	0.00514	0.00864	CcSEcCtD
Eletriptan—Dry skin—Varenicline—nicotine dependence	0.00511	0.00858	CcSEcCtD
Eletriptan—Abdominal pain upper—Varenicline—nicotine dependence	0.00509	0.00855	CcSEcCtD
Eletriptan—HTR1E—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00508	0.0161	CbGpPWpGaD
Eletriptan—Cramp muscle—Varenicline—nicotine dependence	0.00502	0.00843	CcSEcCtD
Eletriptan—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00494	0.0157	CbGpPWpGaD
Eletriptan—Gastritis—Varenicline—nicotine dependence	0.00493	0.00828	CcSEcCtD
Eletriptan—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.0049	0.0155	CbGpPWpGaD
Eletriptan—Abdominal distension—Varenicline—nicotine dependence	0.00485	0.00815	CcSEcCtD
Eletriptan—HTR2B—cardiovascular system—nicotine dependence	0.00482	0.062	CbGeAlD
Eletriptan—Asthma—Varenicline—nicotine dependence	0.00482	0.00809	CcSEcCtD
Eletriptan—Dysphagia—Varenicline—nicotine dependence	0.00482	0.00809	CcSEcCtD
Eletriptan—Angina pectoris—Varenicline—nicotine dependence	0.00469	0.00788	CcSEcCtD
Eletriptan—Bronchitis—Varenicline—nicotine dependence	0.00463	0.00778	CcSEcCtD
Eletriptan—Abdominal discomfort—Varenicline—nicotine dependence	0.00462	0.00776	CcSEcCtD
Eletriptan—Pollakiuria—Varenicline—nicotine dependence	0.00445	0.00747	CcSEcCtD
Eletriptan—Erectile dysfunction—Varenicline—nicotine dependence	0.00443	0.00745	CcSEcCtD
Eletriptan—Weight increased—Varenicline—nicotine dependence	0.00438	0.00736	CcSEcCtD
Eletriptan—HTR1F—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00437	0.0139	CbGpPWpGaD
Eletriptan—Hyperglycaemia—Varenicline—nicotine dependence	0.00434	0.0073	CcSEcCtD
Eletriptan—HTR1A—cardiovascular system—nicotine dependence	0.00432	0.0556	CbGeAlD
Eletriptan—Acute coronary syndrome—Varenicline—nicotine dependence	0.00423	0.00711	CcSEcCtD
Eletriptan—Myocardial infarction—Varenicline—nicotine dependence	0.00421	0.00707	CcSEcCtD
Eletriptan—Stomatitis—Varenicline—nicotine dependence	0.00419	0.00703	CcSEcCtD
Eletriptan—HTR1B—midbrain—nicotine dependence	0.00418	0.0538	CbGeAlD
Eletriptan—Conjunctivitis—Varenicline—nicotine dependence	0.00417	0.00701	CcSEcCtD
Eletriptan—HTR7—cardiovascular system—nicotine dependence	0.00412	0.0531	CbGeAlD
Eletriptan—HTR7—Monoamine GPCRs—DRD2—nicotine dependence	0.00412	0.0131	CbGpPWpGaD
Eletriptan—HTR1E—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00412	0.0131	CbGpPWpGaD
Eletriptan—HTR1D—Monoamine GPCRs—DRD2—nicotine dependence	0.0041	0.013	CbGpPWpGaD
Eletriptan—Epistaxis—Varenicline—nicotine dependence	0.00405	0.0068	CcSEcCtD
Eletriptan—HTR1D—midbrain—nicotine dependence	0.00404	0.0521	CbGeAlD
Eletriptan—Sinusitis—Varenicline—nicotine dependence	0.00403	0.00677	CcSEcCtD
Eletriptan—HTR1B—Monoamine GPCRs—DRD2—nicotine dependence	0.00401	0.0127	CbGpPWpGaD
Eletriptan—Bradycardia—Varenicline—nicotine dependence	0.00392	0.00659	CcSEcCtD
Eletriptan—Hallucination—Varenicline—nicotine dependence	0.00383	0.00644	CcSEcCtD
Eletriptan—Hypoaesthesia—Varenicline—nicotine dependence	0.00383	0.00644	CcSEcCtD
Eletriptan—Urinary tract disorder—Varenicline—nicotine dependence	0.00381	0.0064	CcSEcCtD
Eletriptan—Oedema peripheral—Varenicline—nicotine dependence	0.0038	0.00638	CcSEcCtD
Eletriptan—Urethral disorder—Varenicline—nicotine dependence	0.00378	0.00635	CcSEcCtD
Eletriptan—HTR2B—Monoamine GPCRs—DRD2—nicotine dependence	0.00377	0.012	CbGpPWpGaD
Eletriptan—Visual impairment—Varenicline—nicotine dependence	0.00371	0.00624	CcSEcCtD
Eletriptan—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00366	0.0116	CbGpPWpGaD
Eletriptan—CYP2A6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00361	0.0115	CbGpPWpGaD
Eletriptan—Tinnitus—Varenicline—nicotine dependence	0.00359	0.00604	CcSEcCtD
Eletriptan—Immune system disorder—Varenicline—nicotine dependence	0.00348	0.00585	CcSEcCtD
Eletriptan—HTR7—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00347	0.011	CbGpPWpGaD
Eletriptan—Chills—Varenicline—nicotine dependence	0.00346	0.00581	CcSEcCtD
Eletriptan—HTR1D—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00344	0.0109	CbGpPWpGaD
Eletriptan—Arrhythmia—Varenicline—nicotine dependence	0.00344	0.00579	CcSEcCtD
Eletriptan—HTR1B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00337	0.0107	CbGpPWpGaD
Eletriptan—HTR1A—midbrain—nicotine dependence	0.00337	0.0434	CbGeAlD
Eletriptan—Mesoridazine—DRD2—nicotine dependence	0.00334	0.277	CrCbGaD
Eletriptan—Flatulence—Varenicline—nicotine dependence	0.00331	0.00556	CcSEcCtD
Eletriptan—Dysgeusia—Varenicline—nicotine dependence	0.00329	0.00552	CcSEcCtD
Eletriptan—Back pain—Varenicline—nicotine dependence	0.00325	0.00545	CcSEcCtD
Eletriptan—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00323	0.0102	CbGpPWpGaD
Eletriptan—Muscle spasms—Varenicline—nicotine dependence	0.00323	0.00542	CcSEcCtD
Eletriptan—HTR7—midbrain—nicotine dependence	0.00322	0.0415	CbGeAlD
Eletriptan—HTR2B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00317	0.0101	CbGpPWpGaD
Eletriptan—Tremor—Varenicline—nicotine dependence	0.00314	0.00528	CcSEcCtD
Eletriptan—PTGS1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00314	0.00995	CbGpPWpGaD
Eletriptan—CYP2C9—cardiovascular system—nicotine dependence	0.00312	0.0402	CbGeAlD
Eletriptan—Ill-defined disorder—Varenicline—nicotine dependence	0.00311	0.00523	CcSEcCtD
Eletriptan—Anaemia—Varenicline—nicotine dependence	0.0031	0.00521	CcSEcCtD
Eletriptan—Agitation—Varenicline—nicotine dependence	0.00308	0.00518	CcSEcCtD
Eletriptan—CYP2A6—brain—nicotine dependence	0.00307	0.0396	CbGeAlD
Eletriptan—Angioedema—Varenicline—nicotine dependence	0.00307	0.00515	CcSEcCtD
Eletriptan—HTR1A—Monoamine GPCRs—DRD2—nicotine dependence	0.00306	0.0097	CbGpPWpGaD
Eletriptan—Malaise—Varenicline—nicotine dependence	0.00303	0.00508	CcSEcCtD
Eletriptan—Vertigo—Varenicline—nicotine dependence	0.00301	0.00506	CcSEcCtD
Eletriptan—Syncope—Varenicline—nicotine dependence	0.00301	0.00506	CcSEcCtD
Eletriptan—CYP2A6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00297	0.00941	CbGpPWpGaD
Eletriptan—Palpitations—Varenicline—nicotine dependence	0.00297	0.00498	CcSEcCtD
Eletriptan—Loss of consciousness—Varenicline—nicotine dependence	0.00295	0.00495	CcSEcCtD
Eletriptan—Cough—Varenicline—nicotine dependence	0.00293	0.00492	CcSEcCtD
Eletriptan—Convulsion—Varenicline—nicotine dependence	0.00291	0.00488	CcSEcCtD
Eletriptan—Hypertension—Varenicline—nicotine dependence	0.0029	0.00487	CcSEcCtD
Eletriptan—Myalgia—Varenicline—nicotine dependence	0.00286	0.0048	CcSEcCtD
Eletriptan—Arthralgia—Varenicline—nicotine dependence	0.00286	0.0048	CcSEcCtD
Eletriptan—PTGS1—cardiovascular system—nicotine dependence	0.00285	0.0367	CbGeAlD
Eletriptan—Anxiety—Varenicline—nicotine dependence	0.00285	0.00478	CcSEcCtD
Eletriptan—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00284	0.00477	CcSEcCtD
Eletriptan—Discomfort—Varenicline—nicotine dependence	0.00282	0.00474	CcSEcCtD
Eletriptan—HTR1D—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.0028	0.00887	CbGpPWpGaD
Eletriptan—Dry mouth—Varenicline—nicotine dependence	0.00279	0.00469	CcSEcCtD
Eletriptan—Oedema—Varenicline—nicotine dependence	0.00274	0.0046	CcSEcCtD
Eletriptan—HTR1B—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00274	0.00869	CbGpPWpGaD
Eletriptan—Shock—Varenicline—nicotine dependence	0.00269	0.00453	CcSEcCtD
Eletriptan—Nervous system disorder—Varenicline—nicotine dependence	0.00269	0.00451	CcSEcCtD
Eletriptan—Tachycardia—Varenicline—nicotine dependence	0.00267	0.00449	CcSEcCtD
Eletriptan—Skin disorder—Varenicline—nicotine dependence	0.00266	0.00447	CcSEcCtD
Eletriptan—Hyperhidrosis—Varenicline—nicotine dependence	0.00265	0.00445	CcSEcCtD
Eletriptan—HTR1F—GPCR ligand binding—TAS2R16—nicotine dependence	0.00265	0.0084	CbGpPWpGaD
Eletriptan—HTR1B—brain—nicotine dependence	0.00262	0.0338	CbGeAlD
Eletriptan—Anorexia—Varenicline—nicotine dependence	0.00261	0.00439	CcSEcCtD
Eletriptan—HTR1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00257	0.00815	CbGpPWpGaD
Eletriptan—Hypotension—Varenicline—nicotine dependence	0.00256	0.0043	CcSEcCtD
Eletriptan—HTR1D—brain—nicotine dependence	0.00254	0.0327	CbGeAlD
Eletriptan—Thioridazine—DRD2—nicotine dependence	0.00252	0.209	CrCbGaD
Eletriptan—HTR1E—GPCR ligand binding—TAS2R16—nicotine dependence	0.0025	0.00792	CbGpPWpGaD
Eletriptan—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00249	0.00419	CcSEcCtD
Eletriptan—Insomnia—Varenicline—nicotine dependence	0.00248	0.00416	CcSEcCtD
Eletriptan—Dyspnoea—Varenicline—nicotine dependence	0.00244	0.0041	CcSEcCtD
Eletriptan—Somnolence—Varenicline—nicotine dependence	0.00243	0.00409	CcSEcCtD
Eletriptan—Dyspepsia—Varenicline—nicotine dependence	0.00241	0.00405	CcSEcCtD
Eletriptan—Decreased appetite—Varenicline—nicotine dependence	0.00238	0.004	CcSEcCtD
Eletriptan—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00236	0.00397	CcSEcCtD
Eletriptan—HTR2B—brain—nicotine dependence	0.00236	0.0304	CbGeAlD
Eletriptan—Fatigue—Varenicline—nicotine dependence	0.00236	0.00397	CcSEcCtD
Eletriptan—Pain—Varenicline—nicotine dependence	0.00234	0.00393	CcSEcCtD
Eletriptan—Constipation—Varenicline—nicotine dependence	0.00234	0.00393	CcSEcCtD
Eletriptan—Feeling abnormal—Varenicline—nicotine dependence	0.00226	0.00379	CcSEcCtD
Eletriptan—Gastrointestinal pain—Varenicline—nicotine dependence	0.00224	0.00376	CcSEcCtD
Eletriptan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00223	0.00708	CbGpPWpGaD
Eletriptan—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0022	0.00698	CbGpPWpGaD
Eletriptan—Urticaria—Varenicline—nicotine dependence	0.00218	0.00366	CcSEcCtD
Eletriptan—Body temperature increased—Varenicline—nicotine dependence	0.00216	0.00364	CcSEcCtD
Eletriptan—Abdominal pain—Varenicline—nicotine dependence	0.00216	0.00364	CcSEcCtD
Eletriptan—HTR1A—brain—nicotine dependence	0.00212	0.0273	CbGeAlD
Eletriptan—HTR1A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00209	0.00662	CbGpPWpGaD
Eletriptan—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00205	0.00651	CbGpPWpGaD
Eletriptan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00203	0.00645	CbGpPWpGaD
Eletriptan—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00202	0.00642	CbGpPWpGaD
Eletriptan—HTR7—brain—nicotine dependence	0.00202	0.0261	CbGeAlD
Eletriptan—Hypersensitivity—Varenicline—nicotine dependence	0.00202	0.00339	CcSEcCtD
Eletriptan—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00201	0.00637	CbGpPWpGaD
Eletriptan—Asthenia—Varenicline—nicotine dependence	0.00196	0.0033	CcSEcCtD
Eletriptan—Pruritus—Varenicline—nicotine dependence	0.00194	0.00326	CcSEcCtD
Eletriptan—Diarrhoea—Varenicline—nicotine dependence	0.00187	0.00315	CcSEcCtD
Eletriptan—HTR1F—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00184	0.00585	CbGpPWpGaD
Eletriptan—Dizziness—Varenicline—nicotine dependence	0.00181	0.00304	CcSEcCtD
Eletriptan—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00181	0.00574	CbGpPWpGaD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00179	0.00567	CbGpPWpGaD
Eletriptan—Vomiting—Varenicline—nicotine dependence	0.00174	0.00293	CcSEcCtD
Eletriptan—HTR1E—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00174	0.00552	CbGpPWpGaD
Eletriptan—Rash—Varenicline—nicotine dependence	0.00173	0.0029	CcSEcCtD
Eletriptan—Dermatitis—Varenicline—nicotine dependence	0.00172	0.0029	CcSEcCtD
Eletriptan—Headache—Varenicline—nicotine dependence	0.00172	0.00288	CcSEcCtD
Eletriptan—HTR1F—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00171	0.00543	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—TAS2R16—nicotine dependence	0.0017	0.00541	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—TAS2R16—nicotine dependence	0.00169	0.00537	CbGpPWpGaD
Eletriptan—ABCB1—cardiovascular system—nicotine dependence	0.00169	0.0217	CbGeAlD
Eletriptan—PTGS1—Biological oxidations—CYP2A7—nicotine dependence	0.00167	0.00529	CbGpPWpGaD
Eletriptan—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00166	0.00528	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00166	0.00526	CbGpPWpGaD
Eletriptan—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00165	0.00523	CbGpPWpGaD
Eletriptan—Nausea—Varenicline—nicotine dependence	0.00163	0.00273	CcSEcCtD
Eletriptan—HTR1E—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00161	0.00512	CbGpPWpGaD
Eletriptan—CYP2A6—Biological oxidations—CYP2A7—nicotine dependence	0.00158	0.005	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00156	0.00494	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0015	0.00475	CbGpPWpGaD
Eletriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00147	0.00465	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00141	0.00448	CbGpPWpGaD
Eletriptan—PTGS1—brain—nicotine dependence	0.0014	0.018	CbGeAlD
Eletriptan—HTR1E—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00138	0.00439	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—TAS2R16—nicotine dependence	0.00136	0.00431	CbGpPWpGaD
Eletriptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00134	0.00426	CbGpPWpGaD
Eletriptan—HTR1F—G alpha (i) signalling events—DRD2—nicotine dependence	0.00133	0.00423	CbGpPWpGaD
Eletriptan—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00132	0.0042	CbGpPWpGaD
Eletriptan—ABCB1—midbrain—nicotine dependence	0.00132	0.0169	CbGeAlD
Eletriptan—HTR7—Circadian rythm related genes—CHRNB2—nicotine dependence	0.00131	0.00417	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—TAS2R16—nicotine dependence	0.00128	0.00407	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00126	0.00401	CbGpPWpGaD
Eletriptan—HTR1E—G alpha (i) signalling events—DRD2—nicotine dependence	0.00126	0.00399	CbGpPWpGaD
Eletriptan—HTR1F—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00124	0.00392	CbGpPWpGaD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00119	0.00379	CbGpPWpGaD
Eletriptan—HTR1D—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00118	0.00374	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—FGD1—nicotine dependence	0.00117	0.00372	CbGpPWpGaD
Eletriptan—HTR1E—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00117	0.0037	CbGpPWpGaD
Eletriptan—HTR1B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00115	0.00366	CbGpPWpGaD
Eletriptan—CYP2D6—brain—nicotine dependence	0.00115	0.0148	CbGeAlD
Eletriptan—HTR1F—GPCR ligand binding—OPRM1—nicotine dependence	0.00112	0.00354	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—FGD1—nicotine dependence	0.00111	0.00351	CbGpPWpGaD
Eletriptan—HTR7—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.0011	0.00349	CbGpPWpGaD
Eletriptan—HTR1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00109	0.00347	CbGpPWpGaD
Eletriptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00109	0.00345	CbGpPWpGaD
Eletriptan—HTR1A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00108	0.00344	CbGpPWpGaD
Eletriptan—HTR1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00107	0.0034	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—FGD1—nicotine dependence	0.00107	0.00338	CbGpPWpGaD
Eletriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00106	0.00336	CbGpPWpGaD
Eletriptan—HTR1E—GPCR ligand binding—OPRM1—nicotine dependence	0.00105	0.00334	CbGpPWpGaD
Eletriptan—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00102	0.00323	CbGpPWpGaD
Eletriptan—HTR2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00101	0.00319	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—FGD1—nicotine dependence	0.00101	0.00319	CbGpPWpGaD
Eletriptan—HTR1E—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000999	0.00317	CbGpPWpGaD
Eletriptan—HTR7—Circadian rythm related genes—DRD2—nicotine dependence	0.000972	0.00308	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000963	0.00306	CbGpPWpGaD
Eletriptan—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.00096	0.00305	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000956	0.00304	CbGpPWpGaD
Eletriptan—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000947	0.00301	CbGpPWpGaD
Eletriptan—HTR7—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000943	0.00299	CbGpPWpGaD
Eletriptan—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000937	0.00297	CbGpPWpGaD
Eletriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000937	0.00297	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000937	0.00297	CbGpPWpGaD
Eletriptan—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000929	0.00295	CbGpPWpGaD
Eletriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000917	0.00291	CbGpPWpGaD
Eletriptan—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000883	0.0028	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00088	0.00279	CbGpPWpGaD
Eletriptan—HTR1A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000879	0.00279	CbGpPWpGaD
Eletriptan—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000876	0.00278	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—TAS2R16—nicotine dependence	0.000874	0.00277	CbGpPWpGaD
Eletriptan—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000871	0.00276	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.000869	0.00276	CbGpPWpGaD
Eletriptan—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000864	0.00274	CbGpPWpGaD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000862	0.00274	CbGpPWpGaD
Eletriptan—HTR1D—G alpha (i) signalling events—DRD2—nicotine dependence	0.000852	0.0027	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00085	0.0027	CbGpPWpGaD
Eletriptan—HTR1B—G alpha (i) signalling events—DRD2—nicotine dependence	0.000834	0.00265	CbGpPWpGaD
Eletriptan—ABCB1—brain—nicotine dependence	0.000827	0.0107	CbGeAlD
Eletriptan—HTR1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000816	0.00259	CbGpPWpGaD
Eletriptan—HTR1F—GPCR ligand binding—DRD2—nicotine dependence	0.000807	0.00256	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—TAS2R16—nicotine dependence	0.000802	0.00255	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000799	0.00254	CbGpPWpGaD
Eletriptan—HTR7—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000796	0.00253	CbGpPWpGaD
Eletriptan—HTR1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000791	0.00251	CbGpPWpGaD
Eletriptan—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000774	0.00246	CbGpPWpGaD
Eletriptan—HTR1E—GPCR ligand binding—DRD2—nicotine dependence	0.000761	0.00241	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—TAS2R16—nicotine dependence	0.000757	0.0024	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—FGD1—nicotine dependence	0.000755	0.0024	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—FGD1—nicotine dependence	0.000751	0.00238	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000735	0.00233	CbGpPWpGaD
Eletriptan—HTR2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000727	0.00231	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—OPRM1—nicotine dependence	0.000718	0.00228	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—OPRM1—nicotine dependence	0.000713	0.00226	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000713	0.00226	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000699	0.00222	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000699	0.00222	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—FGD1—nicotine dependence	0.00069	0.00219	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—FGD1—nicotine dependence	0.000686	0.00218	CbGpPWpGaD
Eletriptan—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000682	0.00216	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—FGD1—nicotine dependence	0.000682	0.00216	CbGpPWpGaD
Eletriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000677	0.00215	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—FGD1—nicotine dependence	0.000667	0.00212	CbGpPWpGaD
Eletriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000663	0.00211	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000656	0.00208	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000648	0.00206	CbGpPWpGaD
Eletriptan—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000635	0.00202	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—OPRM1—nicotine dependence	0.000631	0.002	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—FGD1—nicotine dependence	0.00063	0.002	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—FGD1—nicotine dependence	0.000627	0.00199	CbGpPWpGaD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000623	0.00198	CbGpPWpGaD
Eletriptan—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000613	0.00194	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—OPRM1—nicotine dependence	0.000595	0.00189	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—FGD1—nicotine dependence	0.000594	0.00188	CbGpPWpGaD
Eletriptan—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00059	0.00187	CbGpPWpGaD
Eletriptan—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000578	0.00183	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—OPRM1—nicotine dependence	0.000573	0.00182	CbGpPWpGaD
Eletriptan—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00057	0.00181	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.00056	0.00178	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—AKR1B10—nicotine dependence	0.000556	0.00177	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—OPRM1—nicotine dependence	0.00054	0.00171	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000532	0.00169	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—AKR1B10—nicotine dependence	0.000525	0.00167	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—DRD2—nicotine dependence	0.000519	0.00165	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—TAS2R16—nicotine dependence	0.000516	0.00164	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—DRD2—nicotine dependence	0.000516	0.00164	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000513	0.00163	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000508	0.00161	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000505	0.0016	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—DRD2—nicotine dependence	0.000505	0.0016	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000502	0.00159	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—DRD2—nicotine dependence	0.000474	0.00151	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000472	0.0015	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—DRD2—nicotine dependence	0.000456	0.00145	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—DRD2—nicotine dependence	0.00043	0.00136	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—DRD2—nicotine dependence	0.000414	0.00131	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—OPRM1—nicotine dependence	0.000406	0.00129	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—FGD1—nicotine dependence	0.000405	0.00129	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000403	0.00128	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—FGD1—nicotine dependence	0.000403	0.00128	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000395	0.00125	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—FGD1—nicotine dependence	0.000394	0.00125	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—WASF2—nicotine dependence	0.000392	0.00124	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—DRD2—nicotine dependence	0.000391	0.00124	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	0.000385	0.00122	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000383	0.00121	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—WASF1—nicotine dependence	0.000376	0.00119	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000371	0.00118	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—FGD1—nicotine dependence	0.00037	0.00118	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—WASF2—nicotine dependence	0.00037	0.00117	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—OPRM1—nicotine dependence	0.000369	0.00117	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000366	0.00116	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	0.000359	0.00114	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—AKR1B10—nicotine dependence	0.000358	0.00114	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000356	0.00113	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—WASF1—nicotine dependence	0.000354	0.00112	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000348	0.00111	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000342	0.00109	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—OPRM1—nicotine dependence	0.000338	0.00107	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000337	0.00107	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000327	0.00104	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—OPRM1—nicotine dependence	0.000319	0.00101	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000301	0.000955	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—FGD1—nicotine dependence	0.0003	0.000953	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—DRD2—nicotine dependence	0.000293	0.000931	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	0.000292	0.000925	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	0.000285	0.000906	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CYP2A7—nicotine dependence	0.000285	0.000904	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	0.000273	0.000867	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CYP2A7—nicotine dependence	0.000269	0.000855	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—DRD2—nicotine dependence	0.000268	0.000851	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—DRD2—nicotine dependence	0.000266	0.000846	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000265	0.000842	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	0.000265	0.00084	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	0.000259	0.000823	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—WASF2—nicotine dependence	0.000252	0.0008	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—WASF2—nicotine dependence	0.000251	0.000795	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—WASF2—nicotine dependence	0.000245	0.000779	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—DRD2—nicotine dependence	0.000245	0.000776	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—DRD2—nicotine dependence	0.000243	0.000773	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—WASF1—nicotine dependence	0.000242	0.000767	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—WASF1—nicotine dependence	0.00024	0.000762	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—WASF1—nicotine dependence	0.000235	0.000747	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—DRD2—nicotine dependence	0.000231	0.000732	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—WASF2—nicotine dependence	0.00023	0.000731	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—WASF1—nicotine dependence	0.000221	0.000701	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—OPRM1—nicotine dependence	0.000218	0.000691	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	0.000217	0.00069	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	0.000216	0.000686	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	0.000212	0.000672	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—OPRM1—nicotine dependence	0.000199	0.000631	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	0.000197	0.000627	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—WASF2—nicotine dependence	0.000187	0.000593	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—WASF1—nicotine dependence	0.000179	0.000569	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000164	0.000521	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	0.000161	0.000512	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.00016	0.000509	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—DRD2—nicotine dependence	0.000157	0.0005	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—DRD2—nicotine dependence	0.000156	0.000496	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—DRD2—nicotine dependence	0.000153	0.000486	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000151	0.000479	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.00015	0.000475	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—DRD2—nicotine dependence	0.000144	0.000457	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—DRD2—nicotine dependence	0.000117	0.00037	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CYP2A7—nicotine dependence	9.88e-05	0.000313	CbGpPWpGaD
